Zimmer Biomet’s Spin-off of ZimVie to Complete March 1, 2022 Company Updates Competitive Landscape Zimmer Biomet will complete the spin-off of its spine and dental divisions on March 1, 2022, with the debut of ZimVie. Feb 07, 2022
Stryker Enters 2022 With Momentum Company Revenue The Numbers Stryker reported 4Q21 orthopedic sales of $2.4 billion, +13.8% vs. 4Q20. For the full year of 2021, the company’s orthopedic... Jan 28, 2022
ConMed Foresees Hospital Staffing Challenges in 2022 Company Revenue The Numbers The company expects to grow in the mid-single-digits to low double-digits in 2022 but cautioned the year is off to a challenging start. Jan 27, 2022
DePuy Synthes Stabilized Key Segments in 2021 Company Revenue The Numbers The company grew in the double digits versus 2020 but remained slightly below its 2019 baseline as market recovery stalled late in 2021. Jan 26, 2022
Orthopedic Companies Pump Brakes on M&A Activity Competitive Landscape Mergers & Acquisitions M&A transactions increased every year between 2017 and 2020 but slowed considerably in 2021 due to inflated valuations and market disruption. Jan 20, 2022
Orthopedic Sales Unlikely to See Upside in 4Q Earnings Results Market Analysis The Numbers The orthopedic market finds itself in familiar territory in early 2022, with record COVID cases impacting elective surgery volumes. Jan 10, 2022
Stryker’s Return to Orthopedics’ Top Spot Years in the Making Market Analysis The Numbers Stryker and DePuy Synthes have grappled for the top spot in orthopedic sales for decades. We project that Stryker will reclaim the lead in 2021. Dec 13, 2021
Paragon 28 Completes First Quarter as Public Company Company Revenue The Numbers The company grew in the high teens as prior investments in new products and distribution more than offset COVID headwinds. Nov 30, 2021
Medtronic Spine Growth Stymied by COVID Headwinds Company Revenue The Numbers The company grew in the low single digits as enabling technology sales and strength in emerging markets helped offset COVID declines. Nov 29, 2021
Vericel Expects Record MACI Sales to End 2021 Company Revenue The Numbers The company's MACI product declined in the low single digits for 3Q21 but Vericel expects a record-setting fourth quarter. Nov 17, 2021